Skip to content
Disclosery

Parkman Healthcare Partners LLC

Follow

13F filer, CIK 1777015, STAMFORD, CT

Parkman Healthcare Partners LLC reported $976,827,960 across 77 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 33.6% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-001734

Period
2026-06-30
Reported value
$977M
Holdings
77
Top 10 weight
33.6%
New
18
Sold out
31

Largest buys vs the previous quarter

SecurityShares changeApprox. value
INBXnew+256,950$24.3M
UNHnew+55,921$23.2M
VRDNadded+819,640$15.1M
INDVnew+364,269$14.9M
AVTXnew+766,290$14.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KALVexited-1,835,506-$36.9M
SYKreduced-86,798-$27.3M
QGENexited-500,000-$20M
ABBVexited-75,000-$16.3M
LIVNreduced-193,436-$15.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001420506-26-001734, largest first. % of portfolio is the value over $973,687,540, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 170,000 shares; 2025Q1: 328,323 shares; 2025Q2: 871,933 shares; 2025Q3: 773,304 shares; 2025Q4: 885,639 shares; 2026Q1: 800,037 shares; 2026Q2: 800,173 shares 800,173$44.2M4.54%+136Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,384 shares; 2024Q4: 28,163 shares; 2025Q1: 39,191 shares; 2025Q2: 33,296 shares; 2025Q3: 10,000 shares; 2025Q4: not reported; 2026Q1: 34,616 shares; 2026Q2: 35,000 shares 35,000$42M4.31%+384Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 180,000 shares; 2025Q1: 496,736 shares; 2025Q2: 517,807 shares; 2025Q3: 379,486 shares; 2025Q4: 450,212 shares; 2026Q1: 387,306 shares; 2026Q2: 391,791 shares 391,791$40.5M4.16%+4,485Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 70,588 shares; 2024Q4: 78,550 shares; 2025Q1: 130,367 shares; 2025Q2: 225,875 shares; 2025Q3: 171,628 shares; 2025Q4: 587,475 shares; 2026Q1: 689,822 shares; 2026Q2: 534,767 shares 534,767$36M3.7%-155,055Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 195,000 shares; 2024Q4: 177,368 shares; 2025Q1: 280,314 shares; 2025Q2: 181,643 shares; 2025Q3: 202,363 shares; 2025Q4: 160,179 shares; 2026Q1: 431,364 shares; 2026Q2: 435,691 shares 435,691$35.5M3.65%+4,327Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,025,754 shares; 2024Q4: 1,273,789 shares; 2025Q1: 1,215,629 shares; 2025Q2: 599,610 shares; 2025Q3: 652,680 shares; 2025Q4: 968,602 shares; 2026Q1: 1,207,274 shares; 2026Q2: 919,266 shares 919,266$28.3M2.91%-288,008Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 55,000 shares; 2026Q1: 232,093 shares; 2026Q2: 485,661 shares 485,661$26.1M2.68%+253,568Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 425,000 shares; 2024Q4: 1,087,634 shares; 2025Q1: 1,064,506 shares; 2025Q2: 1,298,825 shares; 2025Q3: 1,154,487 shares; 2025Q4: 788,076 shares; 2026Q1: 557,936 shares; 2026Q2: 1,377,576 shares 1,377,576$25.3M2.6%+819,640Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 285,099 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,380 shares; 2025Q4: 99,604 shares; 2026Q1: 403,525 shares; 2026Q2: 669,046 shares 669,046$24.8M2.55%+265,521Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 256,950 shares 256,950$24.3M2.5%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 191,658 shares; 2024Q4: 193,004 shares; 2025Q1: 174,576 shares; 2025Q2: 150,373 shares; 2025Q3: 176,137 shares; 2025Q4: 154,184 shares; 2026Q1: 497,035 shares; 2026Q2: 397,379 shares 397,379$24M2.46%-99,656Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 657,070 shares; 2024Q4: 381,173 shares; 2025Q1: 425,407 shares; 2025Q2: 647,331 shares; 2025Q3: 550,173 shares; 2025Q4: 427,690 shares; 2026Q1: 322,828 shares; 2026Q2: 577,036 shares 577,036$23.4M2.41%+254,208Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 20,000 shares; 2025Q1: 50,213 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 31,875 shares; 2026Q1: not reported; 2026Q2: 55,921 shares 55,921$23.2M2.39%newTimeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 28,000 shares; 2024Q4: 77,717 shares; 2025Q1: 77,690 shares; 2025Q2: 50,376 shares; 2025Q3: 64,108 shares; 2025Q4: 105,472 shares; 2026Q1: 154,771 shares; 2026Q2: 67,973 shares 67,973$21.4M2.2%-86,798Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 109,500 shares; 2025Q3: 30,000 shares; 2025Q4: 35,230 shares; 2026Q1: 86,702 shares; 2026Q2: 105,811 shares 105,811$20.4M2.1%+19,109Timeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,500 shares; 2025Q2: 240,395 shares; 2025Q3: 251,420 shares; 2025Q4: 151,049 shares; 2026Q1: 269,557 shares; 2026Q2: 232,557 shares 232,557$20M2.06%-37,000Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 159,689 shares; 2024Q4: 125,761 shares; 2025Q1: 130,514 shares; 2025Q2: 105,762 shares; 2025Q3: 116,238 shares; 2025Q4: 140,860 shares; 2026Q1: 156,561 shares; 2026Q2: 131,378 shares 131,378$20M2.05%-25,183Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,981 shares; 2025Q4: 249,357 shares; 2026Q1: 411,227 shares; 2026Q2: 721,181 shares 721,181$19.8M2.04%+309,954Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 508,283 shares; 2024Q4: 526,973 shares; 2025Q1: 594,987 shares; 2025Q2: 867,813 shares; 2025Q3: 846,899 shares; 2025Q4: 574,023 shares; 2026Q1: 901,511 shares; 2026Q2: 877,256 shares 877,256$19.2M1.97%-24,255Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,088,033 shares; 2026Q1: 1,354,800 shares; 2026Q2: 1,288,163 shares 1,288,163$18.4M1.89%-66,637Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 93,753 shares; 2024Q4: 106,987 shares; 2025Q1: 213,418 shares; 2025Q2: 168,884 shares; 2025Q3: 74,330 shares; 2025Q4: 60,514 shares; 2026Q1: 50,123 shares; 2026Q2: 97,280 shares 97,280$18.2M1.87%+47,157Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 101,729 shares; 2024Q4: 174,934 shares; 2025Q1: 166,871 shares; 2025Q2: 175,000 shares; 2025Q3: 275,811 shares; 2025Q4: 410,912 shares; 2026Q1: 403,965 shares; 2026Q2: 210,529 shares 210,529$17.3M1.78%-193,436Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 105,000 shares; 2025Q2: 128,478 shares; 2025Q3: not reported; 2025Q4: 145,000 shares; 2026Q1: 280,575 shares; 2026Q2: 202,907 shares 202,907$16.8M1.73%-77,668Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 464,048 shares; 2024Q4: 216,881 shares; 2025Q1: 1,000,562 shares; 2025Q2: 1,007,992 shares; 2025Q3: 1,012,664 shares; 2025Q4: 900,057 shares; 2026Q1: 1,708,099 shares; 2026Q2: 1,624,279 shares 1,624,279$16.2M1.67%-83,820Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,485 shares; 2024Q4: 38,672 shares; 2025Q1: 68,938 shares; 2025Q2: 92,338 shares; 2025Q3: 87,690 shares; 2025Q4: 47,703 shares; 2026Q1: 26,916 shares; 2026Q2: 50,672 shares 50,672$15.3M1.57%+23,756Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 364,269 shares 364,269$14.9M1.53%newTimeline
NVSTENVISTA HOLDINGS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 711,693 shares; 2026Q2: 553,916 shares 553,916$14.6M1.5%-157,777Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,098 shares; 2026Q2: 205,053 shares 205,053$14.4M1.48%+164,955Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 102,393 shares; 2024Q4: 578,511 shares; 2025Q1: 1,780,454 shares; 2025Q2: 2,107,483 shares; 2025Q3: 1,791,674 shares; 2025Q4: 1,691,585 shares; 2026Q1: 1,721,264 shares; 2026Q2: 1,807,621 shares 1,807,621$14.3M1.47%+86,357Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 766,290 shares 766,290$14.2M1.45%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 503,431 shares; 2026Q1: 522,577 shares; 2026Q2: 948,184 shares 948,184$12.6M1.3%+425,607Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 351,131 shares; 2025Q4: 277,812 shares; 2026Q1: 403,487 shares; 2026Q2: 594,202 shares 594,202$12.6M1.29%+190,715Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 430,155 shares; 2026Q1: 336,519 shares; 2026Q2: 355,443 shares 355,443$11.6M1.19%+18,924Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,899 shares; 2026Q1: 26,447 shares; 2026Q2: 30,206 shares 30,206$11.3M1.16%+3,759Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 429,035 shares 429,035$11.3M1.16%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 113,188 shares 113,188$10.8M1.11%newTimeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 401,730 shares; 2026Q1: 551,815 shares; 2026Q2: 486,984 shares 486,984$10.4M1.07%-64,831Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,458,652 shares; 2026Q1: 1,864,806 shares; 2026Q2: 894,374 shares 894,374$10.4M1.06%-970,432Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 293,928 shares; 2025Q2: 463,601 shares; 2025Q3: 455,523 shares; 2025Q4: 410,249 shares; 2026Q1: 380,137 shares; 2026Q2: 380,354 shares 380,354$10.3M1.05%+217Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,126 shares; 2026Q2: 253,365 shares 253,365$9.81M1.01%+153,239Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 275,000 shares; 2025Q1: 203,833 shares; 2025Q2: 443,422 shares; 2025Q3: 345,356 shares; 2025Q4: 257,382 shares; 2026Q1: 206,842 shares; 2026Q2: 208,170 shares 208,170$9.59M0.98%+1,328Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares 150,000$9.44M0.97%newTimeline
AMRXAMNEAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,752 shares; 2026Q2: 541,190 shares 541,190$9.37M0.96%+240,438Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,125 shares; 2026Q2: 67,267 shares 67,267$8M0.82%+27,142Timeline
CYRXCRYOPORT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 508,324 shares 508,324$7.98M0.82%newTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 447,196 shares; 2024Q4: 337,354 shares; 2025Q1: 225,990 shares; 2025Q2: 283,166 shares; 2025Q3: 434,377 shares; 2025Q4: 500,529 shares; 2026Q1: 448,768 shares; 2026Q2: 180,481 shares 180,481$7.7M0.79%-268,287Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 278,775 shares; 2024Q4: 290,491 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 563,484 shares 563,484$7.35M0.75%newTimeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 650,000 shares; 2025Q3: 579,174 shares; 2025Q4: 381,760 shares; 2026Q1: 621,458 shares; 2026Q2: 398,782 shares 398,782$7.16M0.74%-222,676Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 233,563 shares; 2025Q2: 715,504 shares; 2025Q3: 843,502 shares; 2025Q4: 834,559 shares; 2026Q1: 786,783 shares; 2026Q2: 935,247 shares 935,247$6.47M0.66%+148,464Timeline
RMDRESMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 22,622 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,983 shares 32,983$6.43M0.66%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 347,541 shares; 2024Q4: 369,861 shares; 2025Q1: 393,153 shares; 2025Q2: 176,702 shares; 2025Q3: 402,595 shares; 2025Q4: 168,768 shares; 2026Q1: 275,000 shares; 2026Q2: 174,064 shares 174,064$6.41M0.66%-100,936Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,285 shares; 2026Q1: 21,233 shares; 2026Q2: 36,963 shares 36,963$6.23M0.64%+15,730Timeline
CARLCARLSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 521,123 shares; 2026Q2: 597,318 shares 597,318$6.2M0.64%+76,195Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 714,451 shares 714,451$6.12M0.63%newTimeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 276,154 shares; 2026Q1: 291,378 shares; 2026Q2: 202,417 shares 202,417$5.77M0.59%-88,961Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 185,316 shares; 2024Q4: 216,600 shares; 2025Q1: 231,109 shares; 2025Q2: 362,008 shares; 2025Q3: 378,583 shares; 2025Q4: 374,382 shares; 2026Q1: 373,553 shares; 2026Q2: 328,686 shares 328,686$5.36M0.55%-44,867Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 475,279 shares 475,279$4.84M0.5%-24,721Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 406,702 shares; 2026Q2: 258,684 shares 258,684$4.74M0.49%-148,018Timeline
SISHOULDER INNOVATIONS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 226,212 shares 226,212$4.59M0.47%newTimeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 306,027 shares; 2025Q4: 369,023 shares; 2026Q1: 443,058 shares; 2026Q2: 203,986 shares 203,986$4.19M0.43%-239,072Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 396,336 shares; 2024Q4: 228,334 shares; 2025Q1: 446,106 shares; 2025Q2: 648,871 shares; 2025Q3: 696,980 shares; 2025Q4: 277,181 shares; 2026Q1: 823,763 shares; 2026Q2: 449,943 shares 449,943$3.89M0.4%-373,820Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 328,613 shares; 2024Q4: 330,849 shares; 2025Q1: 351,436 shares; 2025Q2: 404,194 shares; 2025Q3: 405,953 shares; 2025Q4: 601,202 shares; 2026Q1: 674,013 shares; 2026Q2: 641,029 shares 641,029$3.66M0.38%-32,984Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 296,071 shares; 2024Q4: 304,629 shares; 2025Q1: 350,551 shares; 2025Q2: 352,262 shares; 2025Q3: 475,568 shares; 2025Q4: 150,558 shares; 2026Q1: 126,150 shares; 2026Q2: 144,791 shares 144,791$3.45M0.35%+18,641Timeline
MMEDMINIMED GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 317,324 shares; 2026Q2: 226,446 shares 226,446$3.39M0.35%-90,878Timeline
EIKNEIKON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 256,053 shares 256,053$3.34M0.34%newTimeline
VTRSVIATRIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares 200,000$3.18M0.33%newTimeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 111,652 shares; 2025Q2: 192,705 shares; 2025Q3: 221,044 shares; 2025Q4: 218,669 shares; 2026Q1: 252,014 shares; 2026Q2: 138,940 shares 138,940$3.12M0.32%-113,074Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000$2.45M0.25%newTimeline
OPRXOPTIMIZERX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 475,000 shares; 2025Q2: 507,423 shares; 2025Q3: 509,611 shares; 2025Q4: 538,649 shares; 2026Q1: 729,369 shares; 2026Q2: 350,347 shares 350,347$2M0.21%-379,022Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 104,081 shares; 2024Q4: 854,716 shares; 2025Q1: 1,171,416 shares; 2025Q2: 1,235,305 shares; 2025Q3: 2,440,633 shares; 2025Q4: 2,416,518 shares; 2026Q1: 2,416,518 shares; 2026Q2: 2,416,518 shares 2,416,518$1.69M0.17%0Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 45,000 shares 45,000$1.65M0.17%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 206,444 shares; 2024Q4: 207,853 shares; 2025Q1: 611,875 shares; 2025Q2: 605,029 shares; 2025Q3: 500,662 shares; 2025Q4: 727,781 shares; 2026Q1: 755,636 shares; 2026Q2: 646,564 shares 646,564$841K0.09%-109,072Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,700 shares 102,700$823K0.08%newTimeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 154,832 shares; 2024Q4: 154,832 shares; 2025Q1: 154,832 shares; 2025Q2: 154,832 shares; 2025Q3: 154,832 shares; 2025Q4: 154,832 shares; 2026Q1: 154,832 shares; 2026Q2: 154,832 shares 154,832$802K0.08%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,978 shares; 2025Q4: 201,036 shares; 2026Q1: 208,205 shares; 2026Q2: 197,947 shares 197,947$532K0.05%-10,258Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 411,076 shares; 2024Q4: 413,732 shares; 2025Q1: 439,632 shares; 2025Q2: 355,822 shares; 2025Q3: 280,822 shares; 2025Q4: 275,073 shares; 2026Q1: 288,670 shares; 2026Q2: 274,497 shares 274,497$486K0.05%-14,173Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
GRAIL INCGRAIL INC PUTput46,000$3.14Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KALVKALVISTA PHARMACEUTICALS INC1,835,506$36.9Mshares
QGENQIAGEN NV500,000$20Mshares
ABBVABBVIE INC75,000$16.3Mshares
ILMNILLUMINA INC110,370$13.6Mshares
EWEDWARDS LIFESCIENCES CORP167,155$13.4Mshares
NBIXNEUROCRINE BIOSCIENCES INC99,069$13.1Mshares
KNSAKINIKSA PHARMACEUTICALS INTL259,184$12.5Mshares
MCKMCKESSON CORP12,676$11Mshares
NUVLNUVALENT INC88,078$9.02Mshares
AXGNAXOGEN INC268,160$8.88Mshares
IDXXIDEXX LABS INC15,000$8.43Mshares
APGEAPOGEE THERAPEUTICS INC77,686$6.54Mshares
COOCOOPER COS INC89,883$6.43Mshares
TNGXTANGO THERAPEUTICS INC266,127$5.57Mshares
MODERNA INCMODERNA INC100,000$5.08Mput
RAREULTRAGENYX PHARMACEUTICAL IN235,000$4.92Mshares
SUPNSUPERNUS PHARMACEUTICALS85,062$4.4Mshares
CAICARIS LIFE SCIENCES INC229,912$4.11Mshares
CVRXCVRX INC429,507$4.06Mshares
WGSGENEDX HOLDINGS CORP50,778$3.26Mshares
VCYTVERACYTE INC101,237$3.26Mshares
CMPSCOMPASS PATHWAYS PLC554,411$3.07Mshares
SLDBSOLID BIOSCIENCES INC308,844$2.22Mshares
BFLYBUTTERFLY NETWORK INC544,477$2.2Mshares
QDELQUIDELORTHO CORP101,764$1.67Mshares
RXSTRXSIGHT INC249,989$1.54Mshares
QTRXQUANTERIX CORP341,453$1.2Mshares
PLSEPULSE BIOSCIENCES INC50,125$1.08Mshares
MAZEMAZE THERAPEUTICS INC31,844$951Kshares
ADMAADMA BIOLOGICS INC82,443$743Kshares
ARAYACCURAY INC DEL884,578$343Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-001734 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001420506-26-001734 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001420506-26-001072 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001420506-26-000499 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001420506-25-003321 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001420506-25-002082 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001420506-25-001258 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001420506-25-000552 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001420506-24-002511 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001420506-24-001560 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001420506-24-000960 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001420506-24-000380 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001420506-23-002103 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001420506-23-001502 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0001420506-23-000981 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001420506-23-000391 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001420506-22-002160 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001420506-22-001534 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001420506-22-000874 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001420506-22-000292 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001420506-21-001560 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001420506-21-001126 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0001420506-21-000649 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001420506-21-000257 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001420506-20-001273 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001420506-20-000909 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001420506-20-000604 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001420506-20-000244 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set